Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Bacsur Péter and Matuz Mária and Resál Tamás and Miheller Pál and Szamosi Tamás and Schäfer Eszter and Sarlós Patrícia and Iliás Ákos and Szántó Kata Judit and Rutka Mariann and Bálint Anita and Milassin Ágnes and Fábián Anna and Bor Renáta and Szepes Zoltán and Molnár Tamás and Farkas Klaudia: Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 15 (January-December). pp. 1-18. ISSN 1756-283X (2022)

[thumbnail of Bacsur.pdf]
Preview
Text
Bacsur.pdf - Published Version

Download (730kB) | Preview
Creators:
Bacsur Péter MTMT
Matuz Mária MTMT
Resál Tamás MTMT
Miheller Pál
Szamosi Tamás
Schäfer Eszter
Sarlós Patrícia
Iliás Ákos
Szántó Kata Judit MTMT
Rutka Mariann MTMT
Bálint Anita MTMT
Milassin Ágnes MTMT
Fábián Anna MTMT
Bor Renáta MTMT
Szepes Zoltán MTMT
Molnár Tamás MTMT
Farkas Klaudia MTMT
Item Type: Journal Article
Journal or Publication Title: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
Date: 2022
Volume: 15
Number: January-December
Number of Pages: 18
Page Range: pp. 1-18
ISSN: 1756-283X
Faculty/Unit: Faculty of Pharmacy
Albert Szent-Györgyi Medical School
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 33532273
DOI azonosító: https://doi.org/10.1177/17562848221144349
Date Deposited: 2023. Jan. 02. 11:46
Last Modified: 2023. Feb. 02. 13:51
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/25882
Web of Science® Times Cited: 10 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year